Late recurrence of renal solitary fibrous tumour in the contralateral kidney

Samaratunga, Hemamali; Gianduzzo, Tony; Perry-Keene, Joanna; Egevad, Lars; Delahunt, Brett

doi:10.1016/j.pathol.2022.07.015

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Renal SFTs are rare, with most published literature in case reports and small case series [8,9]. Most renal SFTS are benign, with only a few malignant cases reported [3,4,[10][11][12][13][14]. The first case of malignant renal SFT, which resulted in pulmonary metastasis, was reported in 2006 by Fine et al [4].…”

Section: Discussionmentioning

confidence: 99%

CD34-Negative Malignant Renal Solitary Fibrous Tumor: Case Report and Diagnostic Insights

Ramineni,

Numbere

2024

Cureus

View full text Add to dashboard Cite

Solitary fibrous tumors (SFTs) are rare fibroblastic neoplasms with diverse biological behaviors and widespread distribution. Primary renal SFTs are uncommon, and their malignant variants, especially those that are CD34 negative, are even rarer. This study presents a case of malignant renal SFT in a 57-year-old female, focusing on its immunomorphological features. On gross examination, the tumor's large size (11.5 cm) was remarkable. Microscopic analysis showed high cellularity, diffuse sheets of moderately pleomorphic ovoid cells, prominent staghorn vessels, tumor cell necrosis, and a high mitotic count. Immunohistochemistry revealed strong positivity for STAT6, vimentin, and Bcl-2 and, notably, negativity for CD34. The presence of the NAB2::STAT6 gene fusion was confirmed through fluorescence in situ hybridization. This case emphasizes the need to consider SFT in the differential diagnosis of unusual renal tumors, even when CD34 is negative. The infrequency, morphological diversity, and resemblance to other tumors make diagnosing renal SFTs challenging. Accurate identification and classification as benign or malignant are crucial for proper clinical management and prognosis.

show abstract